The Indian Journal of Pediatrics

, Volume 85, Issue 7, pp 510–516 | Cite as

Evaluation of the Protection Provided by Hepatitis B Vaccination in India

  • Jacob PuliyelEmail author
  • Pathik Naik
  • Ashish Puliyel
  • Kishore Agarwal
  • Vandana Lal
  • Nimmi Kansal
  • Devki Nandan
  • Vikas Tripathi
  • Prashant Tyagi
  • Saroj K. Singh
  • Rajeev Srivastava
  • Utkarsh Sharma
  • V. Sreenivas
Original Article



In India, Hepatitis B vaccination is recommended at 6 wk except for hospital-deliveries. The authors examined protection afforded by the birth dose.


A case-control study was done. HBsAg and HBcAb were tested in 2671 children, 1 to 5 y and HBsAb was evaluated in a subset of 1413 children. Vaccination history was recorded. Cases were HBsAg carriers. In another analysis, children who got infected (HBsAg and/or HBcAb positive) were considered as cases. Exposed were the unvaccinated. In another analysis, exposed were those vaccinated without the birth dose.


The odds ratio (OR) for HBsAg positivity with birth vaccination was 0.35 (95% CI 0.19–0.66); while with vaccination at 6 wk was 0.29 (95%CI 0.14–0.61), both compared to unvaccinated. Birth vaccination has no added protection when compared to the unvaccinated. Unvaccinated children in index study had HBsAg positivity of 4.38%. The number needed to treat (NNT) to prevent one case of HBsAg positivity was 32.6 (95% CI, 20.9 to 73.6). The odds of getting HBV infection was 0.42 (CI 0.25–0.68) with birth dose and 0.49 (CI 0.30–0.82) without the birth dose compared to the unvaccinated. Protective antibody (HBsAb) was present in about 70% of the vaccinated. In the unimmunised, in the first 2 y HBsAb protection was present in 40%. The odds ratio (OR) for HBsAb in the fully vaccinated between 4 and 5 y was 1.4 (95%CI 0.9–2.18) compared to the unvaccinated.


The present study lends support to the pragmatic approach of the Government to vaccinate babies born at home starting at 6 wk.


Immunization Passive immunity Hepatitis B surface antigen Hepatitis B core antigen Antibody to hepatitis B surface antigen Antibody to hepatitis B core antigen 



This multicenter study was conceived by JP and designed originally by JP, PN, AP KA and VS. AP developed the computer architecture for data monitoring and VS helped with the statistical analysis. PN was responsible for study in Surat; DN, VT, PT, JP were responsible for study in Delhi centres; SKS and US for UP; RS for Uttarakhand. VL and NK were responsible for testing and interpretation of the test data.

The first draft was written by PN and it was finalised with critical inputs from each of the authors. AP was responsible for the write up on the computer programme used and he overlooks the data availability and will ensure it is available openly with no conditions attached.

Each author has seen the final draft, takes responsibility for its contents and signed the copyright transfer forms. JP will be the guarantor for the study report.

Compliance with Ethical Standards

Conflict of Interest


Source of Funding

Indian Council of Medical Research, Delhi.


  1. 1.
    Batham A, Narula D, Toteja T, Sreenivas V, Puliyel JM. Sytematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44:663–74.PubMedGoogle Scholar
  2. 2.
    Puliyel JM. Policy analysis of the use of hepatitis B, Hemophilius influenzae type B, Steptococcus pneumoniae-conjugate and rotavirus vaccines in the national immunization schedules. Health Econ. 2004;13:1147.CrossRefPubMedGoogle Scholar
  3. 3.
    Dhir V, Mohandas KM. Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol. 1999;18:24–8.PubMedGoogle Scholar
  4. 4.
    Jensen MK, Balistreri WF. Viral hepatitis. In: Kliegman RM, Stanton B, Geme JS, Schor NF, Behrman RE, editors. Nelson Textbook of Pediatrics, 20th ed. New Delhi: Elsevier Science Health Science; 2015.Google Scholar
  5. 5.
    Shah U, Kelly D, Chang MH, et al. Management of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr. 2009;48:399–404.CrossRefPubMedGoogle Scholar
  6. 6.
    Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol. 1987;21:137–45.CrossRefPubMedGoogle Scholar
  7. 7.
    Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;2:CD004790.Google Scholar
  8. 8.
    Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol. 1994;140:734–46.CrossRefPubMedGoogle Scholar
  9. 9.
    Ministry of Health and Family Welfare I. Immunizatio_UIP. wwwmohfwnicin [Internet]. Available at: Accessed on 5th May 2017.
  10. 10.
    Puliyel JM, Rastogi P, Mathew JL. Hepatitis B in India: systematic review & report of the 'IMA sub-committee on immunization'. Indian J Med Res. 2008;127:494–7.PubMedGoogle Scholar
  11. 11.
    Geeta MG, Riyaz A. Prevention of mother to child transmission of hepatitis B infection. Indian Pediatr. 2013;50:189–92.CrossRefPubMedGoogle Scholar
  12. 12.
    Gupta I, Sehgal A, Sehgal R, Ganguly NK. Vertical transmission of hepatitis B in north India. J Hygiene, Epidemiol Microbiol Immunol. 1992;36:263–7.Google Scholar
  13. 13.
    Puri P. Tackling the hepatitis B disease burden in India. J Clin Exp Hepatol. 2014;4:312–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Abass F, Thomas RD, Rajkumar A, Gupta N, Puliyel JM. Controlling perinatally acquired hepatitis B. Indian J Pediatr. 2001;68:365.CrossRefPubMedGoogle Scholar
  15. 15.
    Aggarwal R, Babu JJ, Hemalatha R, Reddy AV, Sharma D, Kumar T. Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study. Indian Pediatr. 2014;51:875–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Indian Association for Study of the Liver (INASL). Hepatitis B in India; therapeutic options and prevention strategies – Consensus statement. Indian J Gastroenterol. 2000;19:C54–66.Google Scholar
  17. 17.
    Borkakoty B, Mahanta J, Biswas D. HBV vaccination in hyperendemic remote tribal areas in India. Vaccine. 2007;25:8347–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: implications for blood transfusion. Indian J Med Res. 2010;132:312–7.PubMedGoogle Scholar
  19. 19.
    Waaijenborg S, Hahne SJ, Mollema L, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208:10–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  • Jacob Puliyel
    • 1
    Email author
  • Pathik Naik
    • 2
  • Ashish Puliyel
    • 3
  • Kishore Agarwal
    • 4
  • Vandana Lal
    • 5
  • Nimmi Kansal
    • 5
  • Devki Nandan
    • 6
  • Vikas Tripathi
    • 7
  • Prashant Tyagi
    • 7
  • Saroj K. Singh
    • 8
  • Rajeev Srivastava
    • 9
  • Utkarsh Sharma
    • 10
  • V. Sreenivas
    • 11
  1. 1.Department of PediatricsSt Stephens HospitalDelhiIndia
  2. 2.Department of PediatricsPathik Children’s HospitalSuratIndia
  3. 3.Consumer CAP HPILondonUK
  4. 4.Department of PediatricsSardarmal Khandaka Memorial HospitalJaipurIndia
  5. 5.Department of BiochemistryDr Lal PathLabsDelhiIndia
  6. 6.Department of Pediatrics, PGIMERDr. RML HospitalNew DelhiIndia
  7. 7.Department of PediatricsPt Madan Mohan Malaviya HospitalDelhiIndia
  8. 8.Department of PediatricsNazareth HospitalAllahabadIndia
  9. 9.Department of PediatricsSGRRIM&S, SMI HospitalDehradunIndia
  10. 10.Department of PediatricsThiranker Mahhavir Medical CollegeMuradabadIndia
  11. 11.Department of BiostatisticsAll India Institute of Medical ScienceDelhiIndia

Personalised recommendations